Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study (Q44606908)
Jump to navigation
Jump to search
scientific article published on 19 July 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study |
scientific article published on 19 July 2004 |
Statements
1 reference
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study (English)
1 reference
Peter Libby
1 reference
Nader Rifai
1 reference
Scott Kinlay
1 reference
Gregory G Schwartz
1 reference
Anders G Olsson
1 reference
William J Sasiela
1 reference
Michael Szarek
1 reference
Peter Ganz
1 reference
Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators
1 reference
19 July 2004
1 reference
1 reference
110
1 reference
4
1 reference
386-391
1 reference
Identifiers
1 reference
1 reference